Trending

JP Morgan

R&D roundup – Sage impresses at JP Morgan

R&D roundup – Sage impresses at JP Morgan

One of the biggest headline-grabbers at the 2019 JP Morgan Healthcare conference this week was Sage Therapeutics unveiling

X

R&D roundup – Sage impresses at JP Morgan

https://pharmaphorum.com/r-d/views-analysis-r-d/rd-roundup-sage-impresses-at-jp-morgan/

Sage soars on postpartum depression data

Sage soars on postpartum depression data

Sage Therapeutics has scored a big win with postpartum depression (PPD) drug SAGE-217, after rolling the dice on

X

Sage soars on postpartum depression data

https://pharmaphorum.com/news/sage-soars-on-postpartum-depression-data/

JP Morgan and Amazon could inform US health policy

JP Morgan and Amazon could inform US health policy

Big data and telehealth could improve US system, says Dimon

X

JP Morgan and Amazon could inform US health policy

https://pharmaphorum.com/news/jp-morgan-amazon-health-scheme-could-inform-us-health-policy/

Despite Trump price concerns, JP Morgan event anticipates M&A boom

Despite Trump price concerns, JP Morgan event anticipates M&A boom

2017 could be a bumper year for M&A – but Trump’s price control threats dominate

X

Despite Trump price concerns, JP Morgan event anticipates M&A boom

https://pharmaphorum.com/news/jp-morgan/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com